Vitamin D3 Treatment Decreases Frequencies of CD16-Positive and TNF-[alpha]-Secreting Monocytes in A...
Vitamin D3 Treatment Decreases Frequencies of CD16-Positive and TNF-[alpha]-Secreting Monocytes in Asthmatic Patients
About this item
Full title
Author / Creator
Publisher
Basel: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Background: Previously, we demonstrated that glucocorticoid (GC) treatment of asthmatic patients resulted in decreasing frequencies of monocyte subsets expressing CD16 and capable of releasing TNF-α. Here, we wished to analyze whether the active form of vitamin D, i.e. vitamin D3, referred to as 1α,25-dihydroxyvitamin D3 [1,25-(OH)2D3] can exert GC...
Alternative Titles
Full title
Vitamin D3 Treatment Decreases Frequencies of CD16-Positive and TNF-[alpha]-Secreting Monocytes in Asthmatic Patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1780519317
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1780519317
Other Identifiers
ISSN
1018-2438
E-ISSN
1423-0097
DOI
10.1159/000380882
